Key facts
- This page summarizes Rhonda J. Robb's Form 4 filing for Cardiovascular Systems Inc.
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Feb 2022, 15:42.
Rhonda J. Robb - 07 Feb 2022 Form 4 Insider Report for Cardiovascular Systems Inc
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- N/A
- Reported as of
- 07 Feb 2022
- Net transaction value
- +$29,326
- SEC form
- 4
- Accepted by SEC
- 09 Feb 2022, 15:42:31 UTC
- Prior SEC filing
- 31 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Nick as Attorney-in-Fact for Rhonda J. Robb pursuant to Power of Attorney previously filed.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rhonda J. Robb filed Form 4 for Cardiovascular Systems Inc on 09 Feb 2022.
Change
- Previous filing in this sequence was filed on 31 Aug 2021.
- Current net transaction value: +$29,326.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CSII
transaction
Common Stock
Purchase
- Transaction value
- $29,326
- Shares
- +1,567
- Change %
- +0.96%
- Price
- $18.72
- Shares after
- 164,104
- Date
- 07 Feb 2022
- Ownership
- Direct
CSII
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,477
- Change %
- +3.3%
- Price
- $0.000000
- Shares after
- 169,581
- Date
- 08 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Restrictions lapse as to 2,739 shares on 2/12/23 and as to 2,738 shares on 2/12/24.